EP300 and head and neck squamous cell carcinoma: Luteolin inhibits cancer in head and neck squamous cell carcinoma (HNSCC) xenograft in a mouse model by inhibiting p300 lysine acetyltransferase activity via acting at multiple levels of gene expression, miRNA expression, and miRNA processing [37].